Cynata Therapeutics Limited

Cynata Therapeutics Limitedverified

CYP.AX

Price:

$0.23

Market Cap:

$51.81M

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and CYP-006TK, a novel polymercoated silicon wound dressing for diabetic wounds. In addition, the company develops products for the treatment of asthma, heart attack, coronary artery disease, acute respiratory distress syndrome, brain cancer, ...[Read more]

Industry

Biotechnology

IPO Date

2007-12-19

Stock Exchange

ASX

Ticker

CYP.AX

The Enterprise Value as of January 2025 (TTM) for Cynata Therapeutics Limited (CYP.AX) is 45.60M

According to Cynata Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 45.60M. This represents a change of 110.17% compared to the average of 21.70M of the last 4 quarters.

Cynata Therapeutics Limited (CYP.AX) Historical Enterprise Value (quarterly & annually)

How has CYP.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Cynata Therapeutics Limited over the last ten years is 50.38M. The current 45.60M Enterprise Value has changed 8.95% with respect to the historical average. Over the past ten years (40 quarters), CYP.AX's Enterprise Value was at its highest in in the June 2019 quarter at 119.36M. The Enterprise Value was at its lowest in in the June 2009 quarter at -1005023.00.

Quarterly (TTM)
Annual

Average

50.38M

Median

42.97M

Minimum

1.97M

Maximum

118.29M

Cynata Therapeutics Limited (CYP.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cynata Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.28%

Maximum Annual Enterprise Value = 118.29M

Minimum Annual Increase = -92.91%

Minimum Annual Enterprise Value = 1.97M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202446.79M2.28%
20231.97M-92.91%
202227.78M-29.04%
202139.15M-21.86%
202050.10M-57.64%
2019118.29M5.76%
2018111.84M189.50%
201738.63M118.93%
201617.65M-65.78%
201551.57M298.62%

Cynata Therapeutics Limited (CYP.AX) Average Enterprise Value

How has CYP.AX Enterprise Value performed in the past?

The current Enterprise Value of Cynata Therapeutics Limited (CYP.AX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

25.51M

5-year avg

33.16M

10-year avg

50.38M

Cynata Therapeutics Limited (CYP.AX) Enterprise Value vs. Peers

How is CYP.AX’s Enterprise Value compared to its peers?

Cynata Therapeutics Limited’s Enterprise Value is

CompanyEnterprise ValueMarket cap

Build a custom stock screener for Cynata Therapeutics Limited (CYP.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cynata Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cynata Therapeutics Limited (CYP.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cynata Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cynata Therapeutics Limited's Enterprise Value?

What is the highest Enterprise Value for Cynata Therapeutics Limited (CYP.AX)?

What is the 3-year average Enterprise Value for Cynata Therapeutics Limited (CYP.AX)?

What is the 5-year average Enterprise Value for Cynata Therapeutics Limited (CYP.AX)?

How does the current Enterprise Value for Cynata Therapeutics Limited (CYP.AX) compare to its historical average?